1. |
Drugs that target pathogenesis of psoriasis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
2. |
A successful method of smuggling genes into brains shows promise in treating various brain disorders, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
3. |
Screening for liver cancer worth it in cirrhosis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
4. |
Reasons for single use of sumatriptan revealed |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
5. |
Omalizumab enhances efficacy of established asthma medications |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 7-8
Susman Ed,
Preview
|
|
摘要:
The addition of the anti-IgE monoclonal antibody omalizumab ['Xolair'] to existing treatment regimens may be beneficial for patients who are unable to achieve adequate control of allergic asthma despite receiving high doses of inhaled corticosteroids. A study presented at the 60th Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) [Denver, US; March 2003] showed that the addition of omalizumab to patients' established regimens reduced the number of asthma deterioration-related incidents by approximately 50%, compared with the existing regimens alone. Omalizumab was also shown to improve quality of life (QOL), and reduce the rates of hospitalisation and emergency-room (ER) visits, compared with corticosteroids and standard asthma drugs used alone.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
6. |
Fosmidomycin shows promising antimalarial activity |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
7. |
Pramlintide improves glycaemic control in type 2 diabetes |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
8. |
Topical calcipotriol is methotrexate-sparing in psoriasis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
9. |
Topiramate effective in migraine prophylaxis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 11-12
Poole Raewyn,
Preview
|
|
摘要:
The established anticonvulsant topiramate ['Topamax'] is effective in preventing migraine, according to data from two phase III studies presented at the 55th Annual Meeting of the American Academy of Neurology [Honolulu, US; March−April 2003]. These studies, MIGR-001 and MIGR-002, involved a total of over 900 patients, and showed that treatment with topiramate at dosages of 100 mg/day or 200 mg/day, compared with placebo, significantly reduced the number of headaches that patients experienced each month, and also their requirement for acute medication. Topiramate was generally well tolerated, with similar proportions of patients in the placebo and active treatment groups completing the studies.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
10. |
A drink containing branched-chain amino acids decreases symptoms of acute mania, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1382,
2003,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|